• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

泌尿科癌症结局与国家人类发展指数的关系：近年来的趋势。

The relationship between urologic cancer outcomes and national Human Development Index: trend in recent years.

机构信息

Department of Urology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.

Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.

出版信息

BMC Urol. 2022 Jan 10;22(1):2. doi: 10.1186/s12894-022-00953-5.

DOI:10.1186/s12894-022-00953-5
PMID:35012527
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8744298/
Abstract

OBJECTIVES

To describe the influence of the socioeconomic development on worldwide age-standardized incidence and mortality rates, as well as mortality-to-incidence ratio (MIR) and 5-year net survival of urologic cancer patients in recent years.

METHODS

The Human Development Index (HDI) values were obtained from the United Nations Development Programme, data on age-standardized incidence/mortality rates of prostate, bladder and kidney cancer were retrieved from the GLOBOCAN database, 5-year net survival was provided by the CONCORD-3 program. We then evaluated the association between incidence/MIR/survival and HDI, with a focus on geographic variability as well as temporal patterns during the last 6 years.

RESULTS

Urologic cancer incidence rates were positively correlated with HDIs, and MIRs were negatively correlated with HDIs. Prostate cancer survival also correlated positively with HDIs, solidly confirming the interrelation among cancer indicators and socioeconomic factors. Most countries experienced incidence decline over the most recent 6 years, and a substantial reduction in MIR was observed. Survival rates of prostate cancer have simultaneously improved.

CONCLUSION

Development has a prominent influence on urologic cancer outcomes. HDI values are significantly correlated with cancer incidence, MIR and survival rates. HDI values have risen along with increased incidence and improved outcomes of urologic caner in recent years.

摘要

目的

描述近年来社会经济发展对全球年龄标准化发病率和死亡率以及肿瘤患者死亡率与发病率比（MIR）和 5 年净生存率的影响。

方法

从联合国开发计划署获取人类发展指数（HDI）值，从 GLOBOCAN 数据库获取前列腺癌、膀胱癌和肾癌的年龄标准化发病率/死亡率数据，CONCORD-3 项目提供 5 年净生存率。然后，我们评估了发病率/MIR/生存率与 HDI 之间的关联，重点关注地理变异性以及过去 6 年的时间模式。

结果

泌尿生殖系统癌症的发病率与 HDI 呈正相关，MIR 与 HDI 呈负相关。前列腺癌的生存率也与 HDI 呈正相关，这有力地证实了癌症指标与社会经济因素之间的相互关系。大多数国家在最近 6 年中经历了发病率的下降，并且 MIR 显著降低。同时，前列腺癌的生存率也得到了改善。

结论

发展对泌尿生殖系统癌症的结局有显著影响。HDI 值与癌症发病率、MIR 和生存率显著相关。近年来，HDI 值随着泌尿生殖系统癌症发病率的增加和结局的改善而上升。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/abe859657299/12894_2022_953_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/eeb26f400cce/12894_2022_953_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/35b47cb9e8b4/12894_2022_953_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/2908f1ecdc75/12894_2022_953_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/492908f1d36c/12894_2022_953_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/abe859657299/12894_2022_953_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/eeb26f400cce/12894_2022_953_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/35b47cb9e8b4/12894_2022_953_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/2908f1ecdc75/12894_2022_953_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/492908f1d36c/12894_2022_953_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17a9/8744298/abe859657299/12894_2022_953_Fig5_HTML.jpg

相似文献

1
The relationship between urologic cancer outcomes and national Human Development Index: trend in recent years.泌尿科癌症结局与国家人类发展指数的关系：近年来的趋势。
BMC Urol. 2022 Jan 10;22(1):2. doi: 10.1186/s12894-022-00953-5.
2
Impact of national Human Development Index on liver cancer outcomes: Transition from 2008 to 2018.国家人类发展指数对肝癌结局的影响：2008 年至 2018 年的转变。
World J Gastroenterol. 2019 Aug 28;25(32):4749-4763. doi: 10.3748/wjg.v25.i32.4749.
3
Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality.人类发展指数与全球膀胱癌、肾癌、前列腺癌和睾丸癌发病率及死亡率的关联。
BJU Int. 2017 Dec;120(6):799-807. doi: 10.1111/bju.13875. Epub 2017 May 8.
4
Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.全球前列腺癌发病率和死亡率：36 个国家时间模式和趋势分析。
Eur Urol. 2016 Nov;70(5):862-874. doi: 10.1016/j.eururo.2016.05.043. Epub 2016 Jun 8.
5
Global Prostate Cancer Incidence and Mortality Rates According to the Human Development Index.根据人类发展指数的全球前列腺癌发病率和死亡率
Asian Pac J Cancer Prev. 2016;17(8):3793-6.
6
Human Development Inequality Index and Cancer Pattern: a Global Distributive Study.人类发展不平等指数与癌症模式：一项全球分布研究。
Asian Pac J Cancer Prev. 2016;17(S3):201-4. doi: 10.7314/apjcp.2016.17.s3.201.
7
Human development index is associated with mortality-to-incidence ratios of gastrointestinal cancers.人类发展指数与胃肠道癌的病死率与发病率比值相关。
World J Gastroenterol. 2013 Aug 28;19(32):5261-70. doi: 10.3748/wjg.v19.i32.5261.
8
The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment.乳腺癌的预后与国家人类发展指数和卫生系统成就相关。
PLoS One. 2016 Jul 8;11(7):e0158951. doi: 10.1371/journal.pone.0158951. eCollection 2016.
9
National HIV/AIDS mortality, prevalence, and incidence rates are associated with the Human Development Index.国家层面的艾滋病毒/艾滋病死亡率、流行率和发病率与人类发展指数相关。
Am J Infect Control. 2014 Oct;42(10):1044-8. doi: 10.1016/j.ajic.2014.06.029.
10
The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection.膀胱癌的全球流行病学：发病率和死亡率趋势的联合回归分析及预测。
Sci Rep. 2018 Jan 18;8(1):1129. doi: 10.1038/s41598-018-19199-z.

引用本文的文献

1
How to Support Participants in Urogenital and Prostate Clinical Trials: A Qualitative Perspective.如何在泌尿生殖系统和前列腺临床试验中支持参与者：定性视角
Psychooncology. 2025 Jul;34(7):e70214. doi: 10.1002/pon.70214.
2
A comparative analysis of global and Chinese trends in the burden of kidney cancer from 1990 to 2021.1990年至2021年全球及中国肾癌负担趋势的比较分析。
Sci Rep. 2025 Feb 7;15(1):4558. doi: 10.1038/s41598-025-88682-1.
3
Qualitative studies on men with prostate cancer: a systematic meta-synthesis.关于前列腺癌男性患者的定性研究：一项系统的元综合分析。

本文引用的文献

1
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.分析前列腺癌中微卫星不稳定性的流行情况及对免疫检查点阻断的反应。
JAMA Oncol. 2019 Apr 1;5(4):471-478. doi: 10.1001/jamaoncol.2018.5801.
2
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.前列腺癌的免疫全景与 PD-L2 作为潜在治疗靶点的提名
J Natl Cancer Inst. 2019 Mar 1;111(3):301-310. doi: 10.1093/jnci/djy141.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Int J Qual Stud Health Well-being. 2025 Dec;20(1):2436720. doi: 10.1080/17482631.2024.2436720. Epub 2024 Dec 24.
4
Air Quality and Cancer Prevalence Trends across the Sub-Saharan African Regions during 2005-2020.2005-2020 年撒哈拉以南非洲地区空气质量与癌症发病率趋势。
Int J Environ Res Public Health. 2022 Sep 9;19(18):11342. doi: 10.3390/ijerph191811342.
全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Global Cancer Inequalities.全球癌症不平等现象。
Front Oncol. 2018 Aug 14;8:293. doi: 10.3389/fonc.2018.00293. eCollection 2018.
5
Health Economic Analysis of Open and Robot-assisted Laparoscopic Surgery for Prostate Cancer Within the Prospective Multicentre LAPPRO Trial.在 Prospective Multicentre LAPPRO 试验中，前列腺癌开放式和机器人辅助腹腔镜手术的健康经济学分析。
Eur Urol. 2018 Dec;74(6):816-824. doi: 10.1016/j.eururo.2018.07.038. Epub 2018 Aug 22.
6
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.机器人辅助根治性膀胱切除术与开放性根治性膀胱切除术治疗膀胱癌的比较（RAZOR）：一项开放标签、随机、3 期、非劣效性试验。
Lancet. 2018 Jun 23;391(10139):2525-2536. doi: 10.1016/S0140-6736(18)30996-6.
7
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.前列腺癌筛查：美国预防服务工作组推荐声明。
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.
8
Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies.2 型糖尿病与男性和女性在两项大型前瞻性队列研究中患肾细胞癌风险的关系。
Diabetes Care. 2018 Jul;41(7):1432-1437. doi: 10.2337/dc17-2518. Epub 2018 Apr 20.
9
A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.DDX31/突变型 p53/EGFR 轴促进肌层浸润性膀胱癌的多步进展。
Cancer Res. 2018 May 1;78(9):2233-2247. doi: 10.1158/0008-5472.CAN-17-2528. Epub 2018 Feb 13.
10
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.全球癌症生存趋势监测 2000-14 年（CONCORD-3）：对来自 71 个国家 322 个基于人群的登记处的 37513025 名诊断患有 18 种癌症之一的患者的个体记录进行分析。
Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.